EU fines US firm Illumina $475 million for jumping gun on buying cancer-screening company Grail
The European Union has slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the 27-nation bloc’s antitrust watchdog
The Independent UK ·